(Q33807772)

29 July 2017

1 reference

title

The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice (English)

1 reference

29 July 2017

Svane IM

1

1 reference

29 July 2017

Boesen M

series ordinal

2

1 reference

29 July 2017

Engel AM

series ordinal

3

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

16

1 reference

29 July 2017

4

1 reference

29 July 2017

223-238

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02785868

29 July 2017

0 references

cites work

Natural immunity to tumours--theoretical predictions and biological observations

1 reference

https://api.crossref.org/works/10.1007%2FBF02785868

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785868

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785868

Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785868

Tumor recognition by the cellular immune system: new aspects of tumor immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785868

Histocompatibility antigens on murine tumors

21 January 2018

1 reference

12 December 2020

A new look at tumour immunology

1 reference

12 December 2020

New tumor antigens recognized by T cells

1 reference

12 December 2020

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

12 December 2020

Neoplasms in the acquired immune deficiency syndrome: the multidisciplinary approach to treatment

1 reference

12 December 2020

Tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience

1 reference

12 December 2020

Expression of beta 2-microglobulin by human benign and malignant mesenchymal and neurogenic tumours

1 reference

12 December 2020

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

12 December 2020

Interferon-gamma-Induced MHC Class I Expression and Defects in Jak/Stat Signalling in Methylcholanthrene-Induced Sarcomas

1 reference

12 December 2020

HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix

1 reference

12 December 2020

Expression of beta 2-microglobulin by premalignant epithelium

1 reference

12 December 2020

Evaluation of multiple biologic parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors

1 reference

12 December 2020

Toward a genetic analysis of tumor rejection antigens.

1 reference

12 December 2020

Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness

1 reference

12 December 2020

Immunotherapy of cancer using cytokine gene-modified tumor vaccines

1 reference

12 December 2020

Tumors of the immunocompromised patient

1 reference

12 December 2020

Do human cancers express shared protective antigens? or the necessity of remembrance of things past

1 reference

12 December 2020

Role of natural killer cells in the destruction of circulating tumor emboli

1 reference

12 December 2020

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

12 December 2020

Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice

1 reference

12 December 2020

Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression

1 reference

12 December 2020

Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines

1 reference

12 December 2020

Role and function of antigen nonspecific suppressor factors

1 reference

12 December 2020

Down-regulation of the antitumor immune response.

1 reference

12 December 2020

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions

1 reference

12 December 2020

Immune response against tumors.

1 reference

12 December 2020

Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses.

1 reference

12 December 2020

Experimental vaccine strategies for cancer immunotherapy.

1 reference

12 December 2020

Non-antibody immunotherapy of cancer

1 reference

12 December 2020

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

1 reference

12 December 2020

The role of natural killer cells in the control of tumor growth and metastasis

1 reference

12 December 2020

A stimulating new approach to cancer treatment

1 reference

12 December 2020

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

12 December 2020

Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules

1 reference

12 December 2020

Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice

1 reference

12 December 2020

Age influence on the immune system

1 reference

12 December 2020

Action of natural killer cells and macrophages in cancer

1 reference

12 December 2020

Costimulation of T cells for tumor immunity.

1 reference

12 December 2020

Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host

1 reference

12 December 2020

New "danger" theory of immunology challenges old assumptions

1 reference

12 December 2020

The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma

1 reference

12 December 2020

Immunodepression and malignancy

1 reference

12 December 2020

Immunodepression by the oncogen does not determine the relationship between tumor latency and immunogenicity

1 reference

12 December 2020

Nonvirus-associated antigens in virus-induced mouse mammary tumors.

1 reference

12 December 2020

1 reference

12 December 2020

Molecular characterization of defective antigen processing in human prostate cancer.

1 reference

12 December 2020

Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors

1 reference

12 December 2020

The concept of immunological surveillance

1 reference

12 December 2020

Suppressor cell function in solid tumor cancer patients

1 reference

12 December 2020

Membranes activate tumor- and virus-specific precursor cytotoxic T lymphocytes in vivo and stimulate tumor-specific T lymphocytes in vitro: implications for vaccination.

1 reference

12 December 2020

Skin cancer in Caucasian renal allograft recipients living in a subtropical climate.

1 reference

12 December 2020

Description of a murine B lymphoma tumor-specific antigen

1 reference

12 December 2020

Relations between Immunity and Malignancy

1 reference

12 December 2020

Identification of peptides for immunotherapy of cancer. It is worth the effort.

1 reference

12 December 2020

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

1 reference

12 December 2020

T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?

1 reference

12 December 2020

Natural killer cell regulation of implantation and early lung growth of H-ras-transformed 10T1/2 fibroblasts in mice.

1 reference

12 December 2020

1 reference

12 December 2020

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

12 December 2020

Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.

1 reference

12 December 2020

HLA class I antigens in human tumors.

1 reference

12 December 2020

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

1 reference

12 December 2020

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

1 reference

12 December 2020

Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells

1 reference

12 December 2020

Tumor-rejection antigens recognized by T lymphocytes

1 reference

12 December 2020

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

1 reference

12 December 2020

Natural history of HLA expression during tumour development.

1 reference

12 December 2020

Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity

1 reference

12 December 2020

Emerging principles for the recognition of peptide antigens by MHC class I molecules

1 reference

12 December 2020

Molecular aberrations in the MHC class I-restricted pathway for antigen presentation in methylcholanthrene sarcomas from nude mice: discrepancies between MHC mRNA and surface protein

1 reference

12 December 2020

Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma

1 reference

12 December 2020

Cytokine combinations in immunotherapy for solid tumors: a review

1 reference

12 December 2020

Neoplastic cells that express low levels of MHC class I determinants escape host immunity.

1 reference

12 December 2020

Immunosuppressive factors in human cancer.

1 reference

12 December 2020

Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response

1 reference

12 December 2020

Tumor immunotherapy: the tumor cell as an antigen-presenting cell

1 reference

12 December 2020

T cell responses to human malignant tumours

1 reference

12 December 2020

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

12 December 2020

Keeping the immune system alerted against cancer

1 reference

12 December 2020

Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice

1 reference

12 December 2020

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

12 December 2020

Alterations in T cells of cancer-bearers: whence specificity?

1 reference

12 December 2020

Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice

1 reference

12 December 2020

Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells

1 reference

12 December 2020

Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter

1 reference

12 December 2020

Heterogeneity of natural killer cells

1 reference

12 December 2020

Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes

1 reference

12 December 2020

Biology of natural killer cells

1 reference

12 December 2020

Role of different T cells sets in the rejection of syngeneic chemically induced tumors

1 reference

12 December 2020

Immunodominance across HLA polymorphism: implications for cancer immunotherapy

1 reference

12 December 2020

Immunity to methylcholanthrene-induced sarcomas

1 reference

12 December 2020

The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects

1 reference

12 December 2020

The Nude Mouse vs. The Hypothesis of Immunological Surveillance

1 reference

12 December 2020

MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors

1 reference

12 December 2020

Spontaneous and induced tumor incidence in germfree "nude" mice

1 reference

12 December 2020

Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas

1 reference

12 December 2020

Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes

1 reference

12 December 2020

Loss of HLA class-I alleles, heavy chains and β2-microglobulin in colorectal cancer

1 reference

12 December 2020

Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals

1 reference

12 December 2020

Vaccine Trials for the Clinician: Prospects for Tumor Antigens

1 reference

12 December 2020

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy

1 reference

12 December 2020

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

1 reference

12 December 2020

MHC antigens and cancer: implications for T-cell surveillance

1 reference

12 December 2020

MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice

1 reference

12 December 2020

Reduced expression of HLA class I and II antigens in colon cancer

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

1 reference

12 December 2020

Antigenicity of murine skin tumors induced by ultraviolet light

1 reference

12 December 2020

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

12 December 2020

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

1 reference

12 December 2020

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

12 December 2020

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

1 reference

12 December 2020

The Susceptibility to Cytotoxic T Lymphocyte Mediated Lysis of Chemically Induced Sarcomas from Immunodeficient and Normal Mice

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma

1 reference

12 December 2020

Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant

1 reference

12 December 2020

Molecular definition of tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

12 December 2020

Clonal analysis of the cytolytic T-cell response to human tumors

1 reference

12 December 2020

Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors

1 reference

12 December 2020

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02785868

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference